Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04853160 · ClinicalTrials.gov registry record
Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information
A clinical trial, sponsored by Takeda.
- Completed
- Registry status
- 24,046
- Enrollment target
NCT04853160 is a clinical trial that has completed, run by Takeda. The registered enrollment target is 24,046 participants.
The verdict
NCT04853160 has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- 24,046 participants
- Enrollment target
Study Summary
The prescribing information provides information on medicines. This study will check the number of patients starting febuxostat and the number of febuxostat users with cardiovascular disease after changes to the prescribing information.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24,046 participants |
| Start Date | 2020-08-15 |
| Est. Completion | 2021-01-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04853160
The ClinicalTrials.gov registry entry for NCT04853160 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24,046 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04853160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04853160 about?
NCT04853160 is a clinical study titled "Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information". The prescribing information provides information on medicines. This study will check the number of patients starting febuxostat and the number of febuxostat users with cardiovascular disease after changes to the prescribing information.
What is the current status of trial NCT04853160?
This trial is currently completed. The enrollment target is 24,046 participants. The study started on 2020-08-15. Estimated completion is 2021-01-05.
Who is sponsoring clinical trial NCT04853160?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.